Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chinese herbs thyroid III formula is an experimental Traditional Chinese Medicine (TCM) preparation developed by the Tianjin Medical University Cancer Institute and Hospital for the treatment of thyroid diseases. It is part of a series of herbal formulations (including formulas I and II) investigated for their ability to manage thyroid conditions, such as nodules and autoimmune disorders, particularly in the context of varying dietary iodine intake. The formula is intended to provide a multi-targeted therapeutic approach, potentially modulating thyroid hormone synthesis and reducing inflammation through the synergistic action of its botanical constituents. It has been evaluated in Phase 1/2 clinical trials to assess its safety profile and preliminary clinical efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chinese herbs thyroid III formula.